Arkema S.A. (OTCMKTS:ARKAY – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 29,100 shares, an increase of 29,000.0% from the December 31st total of 100 shares. Based on an average trading volume of 63,500 shares, the short-interest ratio is currently 0.5 days.
Arkema Price Performance
Shares of ARKAY stock traded down $0.55 on Thursday, reaching $80.22. The company’s stock had a trading volume of 19,224 shares, compared to its average volume of 23,461. The company has a quick ratio of 1.54, a current ratio of 2.11 and a debt-to-equity ratio of 0.48. Arkema has a 12-month low of $71.26 and a 12-month high of $111.79. The company has a market capitalization of $6.10 billion, a P/E ratio of 16.04, a PEG ratio of 0.48 and a beta of 1.23. The stock’s 50 day simple moving average is $76.97 and its 200-day simple moving average is $85.10.
Arkema (OTCMKTS:ARKAY – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter. Arkema had a return on equity of 8.04% and a net margin of 3.82%. The company had revenue of $2.63 billion for the quarter. As a group, equities analysts predict that Arkema will post 8.36 earnings per share for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Report on ARKAY
Arkema Company Profile
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Recommended Stories
- Five stocks we like better than Arkema
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- What is diluted earnings per share (Diluted EPS)?
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- Short Selling: How to Short a Stock
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.